Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: Current status and critical needs

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 6, 2008, Pages 1087-1096

  Griffith, Linda M ^a   Cowan, Morton J ^b   Kohn, Donald B ^c   Notarangelo, Luigi D ^d   Puck, Jennifer M ^e   Schultz, Kirk R ^f   Buckley, Rebecca H ^g   Eapen, Mary ^h   Kamani, Naynesh R ⁱ   O'Reilly, Richard J ^j   Parkman, Robertson ^k   Roifman, Chaim M ^l   Sullivan, Kathleen E ^m   Filipovich, Alexandra H ⁿ   Fleisher, Thomas A ^o   Shearer, William T ^p  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h MEDICAL COLLEGE OF WISCONSIN   (United States)

ⁱ CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^j MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^k CHILDREN S HOSPITAL LOS ANGELES   (United States)

^l HOSPITAL FOR SICK CHILDREN   (Canada)

^m UNIVERSITY OF PENNSYLVANIA   (United States)

ⁿ CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^o NATIONAL INSTITUTES OF HEALTH   (United States)

^p BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

Allogeneic hematopoietic cell transplantation; clinical trial; primary immune deficiency

Indexed keywords

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL PRACTICE; FOLLOW UP; GENOTYPE; HEALTH SURVEY; HUMAN; IMMUNE DEFICIENCY; LONG TERM CARE; MORBIDITY; NEWBORN SCREENING; NORTH AMERICA; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SEVERE COMBINED IMMUNODEFICIENCY; WISKOTT ALDRICH SYNDROME;

DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; EDUCATION; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT, NEWBORN; MULTICENTER STUDIES AS TOPIC; NORTH AMERICA; PILOT PROJECTS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 57149131532     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.09.045     Document Type: Article

References (40)

1. Buckley R.H. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 22 (2004) 625-655
2. Cavazzana-Calvo M., Carlier F., Le Deist F., Morillon E., Taupin P., Gautier D., et al. Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype. Blood 109 (2007) 4575-4581
3. Ochs H.D., and Thrasher A.J. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 117 (2006) 725-738
4. Malech H.L., and Hickstein D.D. Genetics, biology and clinical management of myeloid cell primary immune deficiencies: chronic granulomatous disease and leukocyte adhesion deficiency. Curr Opin Hematol 14 (2007) 29-36
5. Dvorak C.C., and Cowan M.J. Hematopoietic stem cell transplantation for primary immunodeficiency disease. Bone Marrow Transplant 41 (2008) 119-126
6. Gatti R.A., Meuwissen H.J., Allen H.D., Hong R., and Good R.A. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 2 (1968) 1366-1369
7. Bach F.H., Albertini R.J., Joo P., Anderson J.L., and Bortin M.M. Bone marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 2 (1968) 1364-1366
8. Reisner Y., Kapoor N., Kirkpatrick D., Pollack M.S., Cunningham-Rundles S., Dupont B., et al. Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 61 (1983) 341-348
9. Read E.J., and Carter C.S. T-cell depletion of hematopoietic progenitor cell products for allogeneic transplantation. In: Sacher R.A. (Ed). Cellular therapy: new frontiers in transfusion medicine (2002), American Association of Blood Banks, Bethesda 29-44
10. Dvorak C.C., Hung G.-Y., Horn B., Dunn E., Oon C.-Y., and Cowan M.J. Megadose CD34+ cell grafts improve recovery of T cell engraftment but not B cell immunity in patients with severe combined immunodeficiency disease undergoing haplocompatible non-myeloablative transplantation. Biol Blood Marrow Transplant 14 (2008) 1125-1133
11. Barge R.M.Y., Starrenburg C.W.J., Falkenburg J.H.F., Fibbe W.E., Marijt E.W., and Willemze R. Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath "in the bag" as T-cell depletion: the Leiden experience. Bone Marrow Transplant 37 (2006) 1129-1134
12. Buckley R.H., Schiff S.E., Schiff R.I., Markert L., Williams L.W., Roberts J.L., et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 340 (1999) 508-516
13. Friedrich W., Goldmann S.F., Ebell W., Blutters-Sawatzki R., Gaedicke G., Raghavachar A., et al. Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors. Eur J Pediatr 144 (1985) 125-130
14. Dror Y., Gallagher R., Wara D.W., Colombe B.W., Merino A., Benkerrou M., et al. Immune reconstitution in severe combined immunodeficiency disease following lectin-treated, T cell depleted haplocompatible bone marrow transplantation. Blood 81 (1993) 2021-2030
15. Smogorzewska E.M., Brooks J., Annett G., Kapoor N., Crooks G.M., Kohn D.B., et al. T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency. Arch Immunol Ther Exp (Warsz) 48 (2000) 111-118
16. Myers L.A., Patel D.D., Puck J.M., and Buckley R.H. Hematopoietic stem cell transplantation for severe combined immunodeficiency (SCID) in the neonatal period leads to superior thymic output and improved survival. Blood 99 (2002) 872-878
17. Antoine C., Müller S., Cant A., Cavazzana-Calvo M., Veys P., Vossen J., et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 361 (2003) 553-560
18. Mazzolari E., Forino C., Guerci S., Imberti L., Lanfranchi A., Porta F., et al. Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. J Allergy Clin Immunol 120 (2007) 892-899
19. Grunebaum E., Mazzolari E., Porta F., Dallera D., Atkinson A., Reid B., et al. Bone marrow transplantation for severe combined immune deficiency. JAMA 295 (2006) 508-518
20. Roifman C.M., Somech R., and Grunebaum E. Matched unrelated bone marrow transplant for T + combined immunodeficiency. Bone Marrow Transplant 41 (2008) 947-952
21. Knutsen A.P., and Wall D.A. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience. J Clin Immunol 20 (2000) 466-476
22. Eggleston B., Patience M., Edwards S., Adamkiewicz T., Buchanan G.R., Davies S.C., et al. Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia. Br J Haematol 136 (2007) 673-676
23. Gurney J.G., Ness K.K., Rosenthal J., Forman S.J., Bhatia S., and Baker K.S. Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: results from the bone marrow transplant survivor study. Cancer 106 (2006) 1402-1408
24. Antin J.H., Childs R., Filipovich A.H., Giralt S., Mackinnon S., Spitzer T., et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 tandem meetings of the International Bone Marrow Transplant Registry and the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 7 (2001) 473-485
25. Booth C., Ribeil J.A., Audat F., Dal-Cortivo L., Veys P.A., Thrasher A.J., et al. CD34+ stem cell top-ups without conditioning after initial haematopoietic stem cell transplantation for correction of incomplete haematopoietic and immunological recovery in severe congenital immunodeficiencies. Br J Haematol 135 (2006) 533-537
26. Horn B., Viele M., Mentzer W., Mogck N., DeSantes K., and Cowan M.J. Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation. Bone Marrow Transplant 24 (1999) 1009-1013
27. Chan K., and Puck J.M. Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol 115 (2005) 391-398
28. Puck J.M., and SCID Newborn Screening Working Group. Population-based newborn screening for severe combined immunodeficiency: steps toward implementation. J Allergy Clin Immunol 120 (2007) 760-768
29. Li L., Moshous D., Zhou Y., Wang J., Xie G., Salido E., et al. A founder mutation in Artemis, an SNM1-like protein, causes severe combined immunodeficiency disease in Athabascan-speaking Native Americans. J Immunol 168 (2002) 6323-6329
30. Conley M.E., Saragoussi D., Notarangelo L., Etzioni A., and Casanova J.-L. PAGID (Pan-American Group for Immunodeficiencies), ESID (European Society for Immunodeficiencies). An international study examining therapeutic options used in treatment of Wiskott-Aldrich syndrome. Clin Immunol 109 (2003) 272-277
31. Dupuis-Girod S., Medioni J., Haddad E., Quartier P., Cavazzana-Calvo M., Le Deist F., et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 111 (2003) e622-e627
32. Sullivan K.E., Mullen C.A., Blaese R.M., and Winkelstein J.A. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125 (1994) 876-885
33. Filipovich A.H., Stone J.V., Tomany S.C., Ireland M., Kollman C., Pelz C.J., et al. Impact of donor type on outcome of bone marrow transplantation for Wiscott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 97 (2001) 1598-1603
34. Bolinger A.M., Zangwill A.B., Slattery J.T., Risler L.J., Sultan D.H., Glidden D.V., et al. Target dose adjustment of busulfan in pediatric patients undergoing bone marrow transplantation. Bone Marrow Transplant 28 (2001) 1013-1018
35. Ozsahin H., Cavazzana-Calvo M., Notarangelo L.D., Schulz A., Thrasher A.J., Mazzolari E., et al. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. Blood 111 (2008) 439-445
36. Martire B., Rondelli R., Soresina A., Pignata C., Broccoletti T., Finocchi A., et al. Clinical features, long term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study. Clin Immunol 126 (2008) 155-164
37. Horwitz M.E., Barrett A.J., Brown M.R., Carter C.S., Childs R., Gallin J.I., et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med 344 (2001) 881-888
38. Seger R.A., Gungor T., Belohradsky B.H., Blanche S., Bordigoni P., Di Bartolomeo P., et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood 100 (2002) 4344-4350
39. Petersdorf E.W. Optimal HLA matching in hematopoietic cell transplantation. Curr Opin Immunol 20 (2008) 1-6
40. Rao K., Amrolia P.J., Jones A., Cale C.M., Naik P., King D., et al. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced intensity conditioning regimen. Blood 105 (2005) 879-885